Monarch Partners Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $397K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $782K | Buy |
|
|||||
|
2022
Q1 | $647K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $425K | Buy |
|
|||||
|
2020
Q2 | $245K | Sell |
|
|||||
|
2020
Q1 | $3.59M | Buy |
|
|||||
|
2019
Q4 | $422K | Sell |
|
|||||
|
2019
Q3 | $6.32M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $6.56M | Sell |
|
|||||
|
2018
Q4 | $6.17M | Sell |
|
|||||
|
2018
Q3 | $14.6M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $3.83M | Sell |
|
|||||
|
2017
Q3 | $5.84M | Sell |
|
|||||
|
2017
Q2 | $8.16M | Sell |
|
|||||
|
2017
Q1 | $11.3M | Sell |
|
|||||
|
2016
Q4 | $17.6M | Buy |
|
|||||
|
2016
Q3 | $10.5M | Buy |
|
|||||
|
2016
Q2 | $9.96M | Sell |
|
|||||
|
2016
Q1 | $17M | Buy |
|
|||||
|
2015
Q4 | $6.98M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $2.4M | Sell |
|
|||||
|
2014
Q4 | $7.11M | Sell |
|
|||||
|
2014
Q3 | $9.68M | Buy |
|
|||||
|
2014
Q2 | $6.13M | Buy |
|
|||||
|
2014
Q1 | $6.4M | Buy |
|
|||||
|
2013
Q4 | $1.35M | Buy |
|